GBLX

GB Sciences, Inc. GBLX

GBLX
GB Sciences, Inc. MOBO
Mobile Lads Corp. SCPX
Scorpius Holdings, Inc. AMPE
Ampio Pharmaceuticals, Inc. NBIO
Nascent Biotech, Inc. USRM
U.S. Stem Cell, Inc. RNUGF
ReNeuron Group plc EMED
Electromedical Technologies, Inc. JNHMF
Jack Nathan Medical Corp. AMBS
Amarantus BioScience Holdings, Inc.

Résultat net

EBITDA

P/E Ratio

Capitalisation

Performance

Periode GBLX MOBO SCPX AMPE NBIO USRM RNUGF EMED JNHMF AMBS
6M 200.00 % 0.00 % -84.29 % 3 885.71 % -69.23 % 0.00 % 0.00 % -50.00 % -90.00 % -40.00 %
YTD -86.67 % 0.00 % -99.84 % 3 119.23 % -98.42 % 0.00 % 0.00 % -75.00 % -91.11 % 200.00 %
1Y 500.00 % -96.55 % -99.93 % 3 704.55 % -99.02 % 0.00 % 0.00 % -75.00 % -97.58 % 200.00 %
3Y -97.86 % -98.89 % -100.00 % -99.07 % -99.65 % -98.00 % -99.52 % -99.19 % -99.11 % -86.96 %
5Y -97.86 % -99.55 % -100.00 % -99.97 % -98.70 % -98.33 % -99.91 % -99.97 % -99.96 % -94.96 %
10Y -99.84 % -99.90 % -100.00 % -99.89 % -99.62 % -99.99 % -99.99 % -99.97 % -99.96 % -99.97 %
Depuis le début -99.99 % -99.97 % -100.00 % -99.90 % -98.40 % -100.00 % -100.00 % -99.97 % -99.96 % 421 840.93 %

Dividende